Work

Phase 2 trial of TIL therapy for metastatic uveal melanoma: Evaluation of T cell potency and an in situ precision biomarker.

Year: 2026

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2026.44.16_suppl.2512

Authors: Shravan Leonard-Murali, Chetana Bhaskarla, Ghanshyam S. Yadav, Alquama Lokhandwala, Josh A. Tobin, Kristen Maurer, Allyson Welsch, Lorenzo Sellitto, Qiyiwen Zhang, Brigitte Senechal, Devanjan Sikdar, Udai Kammula

Institutions: UPMC Hillman Cancer Center, University of Pittsburgh Medical Center

Language: English

Topic: Ocular Oncology and Treatments

Subfield: Ophthalmology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W7162488066

Cites:

Cited by:

Related to: